Comparison of the effect of region-of-interest methods using gadoxetic acid-enhanced MR imaging with diffusion-weighted imaging on staging hepatic fibrosis

[1]  F. Sperati,et al.  Relationship between diffusion parameters derived from intravoxel incoherent motion MRI and perfusion measured by dynamic contrast‐enhanced MRI of soft tissue tumors , 2016, NMR in biomedicine.

[2]  Eun Sun Lee,et al.  Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging , 2016, European Radiology.

[3]  Y. Ding,et al.  Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging. , 2015, Clinical radiology.

[4]  Yu Hu,et al.  Real‐time Tissue Elastography for Assessment of Liver Stiffness in Adults Without Known Liver Disease , 2015, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[5]  T. Takayama,et al.  Management before hepatectomy for hepatocellular carcinoma with cirrhosis. , 2015, World journal of hepatology.

[6]  Jean-Luc Daire,et al.  Advanced fibrosis: Correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver. , 2015, Radiology.

[7]  Christophe Aubé,et al.  Imaging modalities for the diagnosis of hepatic fibrosis and cirrhosis. , 2015, Clinics and research in hepatology and gastroenterology.

[8]  Hiroshi Onishi,et al.  Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis. , 2015, Magnetic resonance imaging.

[9]  I. Guha,et al.  Non-invasive monitoring of liver fibrosis. , 2014, British medical bulletin.

[10]  Ş. Yıldız,et al.  The value of liver and spleen ADC measurements in the diagnosis and follow up of hepatic fibrosis in chronic liver disease , 2014, Acta clinica Belgica.

[11]  J. Stoker,et al.  Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C , 2014, European Radiology.

[12]  Michael Haimerl,et al.  Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions , 2013, BMC Medical Imaging.

[13]  S. Cho,et al.  Noninvasive assessment of hepatic fibrosis using gadoxetate-disodium-enhanced 3T MRI. , 2013, Annals of hepatology.

[14]  吉村 宜高.  Distinguishing hepatic hemangiomas from metastatic tumors using T1 mapping on gadoxetic-acid-enhanced MRI , 2013 .

[15]  J. Ledsam,et al.  Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention , 2013, European Radiology.

[16]  Hyung Jin Won,et al.  Assessment of Hepatic Function with Gd-EOB-DTPA-Enhanced Hepatic MRI , 2012, Digestive Diseases.

[17]  Laurent Castera,et al.  Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. , 2011, Best practice & research. Clinical gastroenterology.

[18]  Noriyuki Moriyama,et al.  Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations. , 2011, Radiology.

[19]  T. Murakami,et al.  New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI. , 2010, European journal of radiology.

[20]  Gérard Forzy,et al.  Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C , 2009, Hepatology.

[21]  Fabrice Carrat,et al.  Liver biopsy: the best, not the gold standard. , 2009, Journal of hepatology.

[22]  L. Castéra.  Assessing liver fibrosis , 2008, Expert review of gastroenterology & hepatology.

[23]  V. de Lédinghen,et al.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. , 2005, Gastroenterology.

[24]  L. Castéra,et al.  Patient-administered nitrous oxide/oxygen inhalation provides safe and effective analgesia for percutaneous liver biopsy: a randomized placebo-controlled trial. , 2001 .

[25]  L. Castéra,et al.  Patient-administered nitrous oxide/oxygen inhalation provides safe and effective analgesia for percutaneous liver biopsy: A randomized placebo-controlled trial , 2001, American Journal of Gastroenterology.